Abstract:We performed this systematic review and meta-analysis to evaluate the association between antioxidant supplementation and PCOS patients. The following databases were searched through March 2023: PubMed, Embase, The Cochrane Library, and Web of Science. This study included a total of 49 articles and 62 studies, and the sample consisted of 1657 PCOS patients from the antioxidant group and 1619 PCOS patients from the placebo group. The meta-analysis revealed that fasting blood glucose (FBG) levels (standardized squared variance (SMD)): -0.31 [95% CI: -0.39,- 0.22], p < 0.00001), the steady-state model assessment of insulin resistance(HOMA-IR) (SMD: -0.68 [95%, -0.87, -0.50], p < 0.00001) and insulin levels (SMD): -0.68 [95%, -0.79, -0.58], p <0.00001) in PCOS patients taking antioxidants were significantly lower than those in the placebo group. Compared with the placebo group, total cholesterol (TC) levels (SMD: -0.38[95%:-0.56,-0.20], p<0.001), low-density lipoprotein (LDL-C) levels (SMD: -0.24 [95%:-0.37, -0.10], p = 0.0008) and very low-density lipoprotein (VLDL) levels (SMD: -0.53 [95%:-0.65, -0.41], p < 0.00001) is lower in PCOS patients taking antioxidant supplements. Total testosterone (TT)(SMD:-0.78[95%:-1.15,-0.42],p<0.0001),dehydroepiandrosterone(DHEAS)(SMD:-0.42[95%:-0.58,-0.25],p<0.00001), and MF-G SCORES (SMD:-0.63[95%:-0.98,-0.28], p=0.0004) in patients taking antioxidant supplements is lower residually. C-reactive protein (CRP) levels (SMD:-0.48[95%: -0.63, -0.34], p < 0.000001), BMI (MD: -0.27[95%, -0.50, -0.03], p = 0.03), weight (MD: -0.73[95%, -1.35, -0.11, p = 0.02), diastolic blood pressure (MD: -3.78 [95%: -6.30,-1.26], p =0.003) is significantly lower. In addition, compared with the placebo group, The sex hormone binding protein (SHBG) level (SMD:0.23[95%:0.07,0.38], p=0.004), high-density lipoprotein (HDL-C)level (SMD:0.11[95%:0.01,0.20], p=0.03), total antioxidant capacity (TAC) level (SMD:0.59[95%:0.31,0.87], p<0.0001) and quantitative insulin sensitivity index (QUICKI) level (MD:0.01[95%:0.01,0.02], p <0.00001) were higher of PCOS patients who took antioxidant supplements. Antioxidant supplements did not affect other analyzed parameters in PCOS patients, including follicle-stimulating hormone (FSH), free androgen index (FAI), NO, glutathione (GSH), malondialdehyde (MDA), and diastolic blood pressure (DBP). Our study may provide a new treatment strategy for clinical PCOS patients, and more high-quality trials are expected to be carried out, especially for PCOS patients in Western countries, where lacks trials of antioxidant intervention in PCOS patients.

Activity of LPO Processes in Women with Polycystic Ovarian Syndrome and Infertility

160.Ovarian Leukocytes and Cytokines in Polycystic Ovary Syndrome

Evaluation of Oxytocin Level and Its Relationship With Oxidant-Antioxidant Status in Women With Polycystic Ovarian Syndrome

Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome

Oxidative stress and polycystic ovary syndrome: evaluation during ovarian stimulation for ICSI

[Serum markers of oxidative stress and assisted reproduction procedures results in infertile patients with polycystic ovary syndrome and controls]

[The effects of oxidative stress to PCOS]

Omega-3 and vitamin E co-supplementation can improve antioxidant markers in obese/overweight women with polycystic ovary syndrome

A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS

Hormonal profile in women with infertility against the background of polycystic ovary syndrome depending on the type of pre-pregnancy pre-treatment

Relationship between Serum Levels of Oxidative Stress Markers and Metabolic Syndrome Components in PCOS Women

The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome

Ascorbic Acid and Alpha-Tocopherol Contribute to the Therapy of Polycystic Ovarian Syndrome in Mouse Models

Oxidative Stress in Granulosa Cells Contributes to Poor Oocyte Quality and IVF-ET Outcomes in Women with Polycystic Ovary Syndrome

Efficacy of Antioxidant Supplementation in Improving Endocrine, Hormonal, Inflammatory, and Metabolic Statuses of PCOS: A Meta-analysis and Systematic Review

Polycystic Ovary Syndrome and Oxidative Stress. Natural Treatments

Follicular Free Fatty Acid Metabolic Signatures and Their Effects on Oocyte Competence in Non-Obese PCOS Patients

Oxidative Imbalance in Endometriosis-Related Infertility—The Therapeutic Role of Antioxidants

The effectiveness of coenzyme Q10, vitamin E, inositols, and vitamin D in improving the endocrine and metabolic profiles in women with polycystic ovary syndrome: a network Meta-analysis

Association of Free Radical Product and Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis

Disturbed Follicular Microenvironment in Polycystic Ovary Syndrome: Relationship to Oocyte Quality and Infertility